v::NTRK3
About
Gene context: NTRK3
Biomarker Type: Rearrangement
Present: True
Rearrangement Type: Fusion
Legacy biomarker representation, assumes GRCh37 / hg19 genome build.
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | v::NTRK3 | Any solid tumor | Repotrectinib | FDA |
| Sensitivity (+) | v::NTRK3 | Any solid tumor | Larotrectinib | FDA |
| Sensitivity (+) | v::NTRK3 | Any solid tumor | Larotrectinib | HC |
| Sensitivity (+) | v::NTRK3 | Any solid tumor | Entrectinib | FDA |
| Sensitivity (+) | v::NTRK3 | Any solid tumor | Entrectinib | HC |